AR042107A1 - Composiciones dieteticas - Google Patents
Composiciones dieteticasInfo
- Publication number
- AR042107A1 AR042107A1 ARP030104300A ARP030104300A AR042107A1 AR 042107 A1 AR042107 A1 AR 042107A1 AR P030104300 A ARP030104300 A AR P030104300A AR P030104300 A ARP030104300 A AR P030104300A AR 042107 A1 AR042107 A1 AR 042107A1
- Authority
- AR
- Argentina
- Prior art keywords
- serum protein
- dietary compositions
- diet compositions
- palatine
- lecithins
- Prior art date
Links
- 230000037213 diet Effects 0.000 title 1
- 235000005911 diet Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 2
- 102000004506 Blood Proteins Human genes 0.000 abstract 2
- 235000007882 dietary composition Nutrition 0.000 abstract 2
- 239000003531 protein hydrolysate Substances 0.000 abstract 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
- 102000004889 Interleukin-6 Human genes 0.000 abstract 1
- 108090001005 Interleukin-6 Proteins 0.000 abstract 1
- 239000005642 Oleic acid Substances 0.000 abstract 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 102100040247 Tumor necrosis factor Human genes 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940100601 interleukin-6 Drugs 0.000 abstract 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 235000014593 oils and fats Nutrition 0.000 abstract 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/068—Particular types of cheese
- A23C19/076—Soft unripened cheese, e.g. cottage or cream cheese
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
Abstract
Composiciones dietéticas que comprenden como ingredientes esenciales: hidrolizados de proteínas séricas; lecitinas y aceites y grasas ricos en ácido oleico, que permiten mejorar el metabolismo de los lípidos: y palatinosa que posee un efecto economizador de insulina. Aún más, se encontró que el hidrolizado de proteínas séricas incluido en las composiciones dietéticas suprimía la producción inducida por endotoxinas de TNF-a e interleuquina 6 en macrófagos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002339948 | 2002-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR042107A1 true AR042107A1 (es) | 2005-06-08 |
Family
ID=32375794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030104300A AR042107A1 (es) | 2002-11-22 | 2003-11-20 | Composiciones dieteticas |
Country Status (17)
Country | Link |
---|---|
US (2) | US7563458B2 (es) |
EP (1) | EP1575379B1 (es) |
JP (3) | JP2006515287A (es) |
KR (1) | KR101038354B1 (es) |
CN (1) | CN100393243C (es) |
AR (1) | AR042107A1 (es) |
AT (1) | ATE468762T1 (es) |
BR (1) | BR0316512A (es) |
CA (1) | CA2506603C (es) |
DE (1) | DE60332760D1 (es) |
DK (1) | DK1575379T3 (es) |
ES (1) | ES2344640T3 (es) |
HK (1) | HK1083174A1 (es) |
MY (1) | MY169519A (es) |
NZ (1) | NZ540775A (es) |
TW (1) | TWI317636B (es) |
WO (1) | WO2004047566A1 (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4947636B2 (ja) | 2004-03-31 | 2012-06-06 | カルピス株式会社 | 肝障害予防又は抑制剤 |
US20110274755A1 (en) * | 2004-04-22 | 2011-11-10 | Smith Howard J | Supportive treatment of liver disease |
JP5002857B2 (ja) * | 2004-07-09 | 2012-08-15 | 株式会社明治 | Pparおよび/またはppar関連因子産生増強組成物 |
EP1901620B1 (en) * | 2005-05-31 | 2020-07-01 | Arla Foods Amba | Phosphatidylserine enriched milk fractions for the formulation of functional foods |
KR101375933B1 (ko) * | 2005-06-24 | 2014-03-18 | 카오카부시키가이샤 | 야채즙 및/또는 과즙 함유 용기 담긴 음료 |
DE102006017611A1 (de) * | 2006-04-12 | 2007-10-25 | Südzucker AG Mannheim/Ochsenfurt | Kohlenhyrathaltige Sportgetränke |
US20090280187A1 (en) * | 2006-04-21 | 2009-11-12 | Chavez Montes Bruno Edgar | Oxidation-Stable Granulate Containing Unsaturated Fatty Acids |
US9662368B2 (en) * | 2006-06-15 | 2017-05-30 | Murray Goulburn Co-Operative., Limited | Formulation comprising whey protein and hydrolysates for improving muscle recovery |
DE102007009029A1 (de) * | 2007-02-23 | 2008-09-04 | Südzucker AG Mannheim/Ochsenfurt | Niedrig-glykämische Mischungen |
US9420807B2 (en) | 2007-04-02 | 2016-08-23 | Purina Animal Nutrition Llc | Method of feeding young monogastric mammals and composition fed to young monogastric mammals |
NZ555163A (en) * | 2007-05-14 | 2010-05-28 | Fonterra Co Operative Group | Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
WO2009023903A1 (en) * | 2007-08-17 | 2009-02-26 | Murray Goulburn Co-Operative Co. Limited | Compositions comprising phospholipids |
JP4941666B2 (ja) * | 2007-10-19 | 2012-05-30 | 松谷化学工業株式会社 | 食物繊維強化剤及び食品 |
US8361534B2 (en) * | 2007-12-20 | 2013-01-29 | Abbott Laboratories | Stable nutritional powder |
AU2008343689A1 (en) * | 2007-12-20 | 2009-07-09 | Abbott Laboratories | Stable nutritional powder |
FI122252B (fi) * | 2008-01-04 | 2011-10-31 | Valio Oy | Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä |
US20110130637A1 (en) * | 2008-03-20 | 2011-06-02 | University Of Dundee | Protein product for modifying cardiovascular health |
DE102008032828A1 (de) * | 2008-07-02 | 2010-01-07 | Technische Universität Dresden | Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel |
DK2380582T4 (da) * | 2009-01-19 | 2019-06-11 | Nutri Co Ltd | Ernæringssammensætning med lav koncentration |
WO2010097484A2 (es) * | 2009-02-25 | 2010-09-02 | Productos Carnicos Elaborados Con Aceite De Oliva Virgen, S.L. | Composición alimentaria |
EP2413720B1 (en) | 2009-04-02 | 2019-07-17 | Novozymes A/S | Process for making a milk-based protein hydrolysate |
CN107822150A (zh) * | 2009-11-30 | 2018-03-23 | 株式会社明治 | 对小肠有益的营养组合物 |
ES2524067T3 (es) * | 2009-12-04 | 2014-12-03 | Mjn U.S. Holdings Llc | Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia |
JP5779348B2 (ja) * | 2010-12-27 | 2015-09-16 | 日油株式会社 | 酸性液状栄養組成物 |
US9532586B2 (en) | 2011-01-06 | 2017-01-03 | Holista Biotech Sdn. Bhd. | Reduced sodium composition |
US9352495B1 (en) * | 2011-03-14 | 2016-05-31 | HSP Holdings, LLC | Barrier release agent |
FR2976399B1 (fr) | 2011-06-09 | 2013-05-31 | Veolia Proprete | Procede de deconstruction au moins partielle d'un ecran plat de visualisation |
SG11201402693VA (en) * | 2011-11-30 | 2014-09-26 | Meiji Co Ltd | Nutritional composition for improving intestinal flora |
TWI472519B (zh) * | 2011-12-20 | 2015-02-11 | Nat Univ Dong Hwa | 含正-亞丁基苯酞之醫藥組成物用於治療肝損傷及改善肝功能 |
US8927601B2 (en) | 2011-12-20 | 2015-01-06 | National Dong Hwa University | Uses of N-butylidenephthalide in treating a liver injury and improving liver function |
EP2674159B1 (de) * | 2012-06-15 | 2016-04-27 | Phrontier S.A.R.L. | Pharmazeutische Zusammensetzung für die Leber-Regeneration |
WO2014030605A1 (ja) * | 2012-08-20 | 2014-02-27 | 味の素株式会社 | 栄養組成物 |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
WO2015013932A1 (en) * | 2013-07-31 | 2015-02-05 | Meiji Co., Ltd. | Nutritional composition for inhibiting growth of tumor |
DE102013018267A1 (de) * | 2013-10-31 | 2015-04-30 | Jan Berg | Quarkhaltige Zusammensetzung |
ES2544153B1 (es) | 2014-02-24 | 2016-06-06 | Ntd Labs, S.L. | Uso de un hidrolizado de caseína como agente antiviral |
CN104082656B (zh) * | 2014-06-12 | 2017-04-12 | 广东省农业科学院蚕业与农产品加工研究所 | 一种适合肝病病人的营养膳及其制作方法 |
CN104187624B (zh) * | 2014-08-07 | 2016-06-08 | 逯明福 | 综合营养粉及其制备方法 |
EP3200618B2 (en) | 2014-09-30 | 2024-06-12 | Société des Produits Nestlé S.A. | Nutritional composition for use in promoting liver maturation |
WO2016156077A1 (en) * | 2015-03-30 | 2016-10-06 | Nestec S.A. | Milk-based protein hydrolysates and compositions made thereof |
WO2016174651A2 (en) * | 2015-10-01 | 2016-11-03 | Frieslandcampina Nederland B.V. | Liquid nutritional composition comprising micellar casein and hydrolysed whey protein |
CN105520019A (zh) * | 2015-11-25 | 2016-04-27 | 广西巴马活益生生物科技有限公司 | 一种多菌种微生物复合功能型饮料制剂及其制备方法 |
CN108430490A (zh) * | 2015-12-03 | 2018-08-21 | 株式会社明治 | 营养组合物 |
TW201735942A (zh) | 2016-01-22 | 2017-10-16 | Meiji Co Ltd | 內毒素之血中移行抑制用組成物 |
JP6842244B2 (ja) * | 2016-05-10 | 2021-03-17 | 花王株式会社 | アイスクリーム類 |
JP6325036B2 (ja) * | 2016-08-19 | 2018-05-16 | 株式会社明治 | 抗がん剤に起因する末梢神経障害を改善するための組成物 |
KR101837299B1 (ko) | 2016-10-21 | 2018-03-09 | 김나연 | 발효 유청단백질의 제조방법 및 발효 유청단백질 |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
JP7195746B2 (ja) * | 2018-03-20 | 2022-12-26 | 株式会社明治 | 炎症性貧血処置のための組成物 |
CN108707327A (zh) * | 2018-06-14 | 2018-10-26 | 湖北文理学院 | 复合材料及其制备方法 |
FR3083981B1 (fr) * | 2018-07-20 | 2021-01-15 | Semiocare Sas | Compositions a usage cosmetique et dermatologique |
CN110663960A (zh) * | 2019-08-23 | 2020-01-10 | 北京康爱营养医学研究院 | 一种营养组合物及其制备方法、应用 |
KR102690070B1 (ko) | 2021-02-26 | 2024-07-31 | (주)서울에프엔비 | 항산화 기능성이 우수한 유청단백질 가수분해물이 첨가된 발효유 및 그 제조방법 |
CN114271480B (zh) * | 2021-12-31 | 2023-10-20 | 烟台大学 | 一种高稳定性终末期阶段肾病全营养食品乳剂及其制备工艺 |
KR20230165449A (ko) | 2022-05-27 | 2023-12-05 | (주)서울에프엔비 | 피부 노화 예방 기능성 요구르트의 제조방법 및 이를 이용하여 제조한 요구르트 제품 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4600588A (en) | 1980-08-20 | 1986-07-15 | Ernster John H | Milk protein hydrolysate and process of preparation |
JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
EP0312612B1 (en) * | 1987-05-01 | 1993-03-24 | Otsuka Pharmaceutical Co., Ltd. | Nutritive emulsion |
EP0421309B2 (en) | 1989-10-02 | 2001-08-16 | Novartis Nutrition AG | Protein hydrolysates |
JPH03167723A (ja) | 1989-11-27 | 1991-07-19 | Matsushita Electric Works Ltd | サーモスイッチ |
US5198250A (en) | 1990-07-16 | 1993-03-30 | Lipotech Partners Limited Partnership | Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
ES2033193B1 (es) | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
AU656977B2 (en) * | 1991-05-31 | 1995-02-23 | Danmark Protein A/S | Method for production of a whey protein hydrolyzate |
JPH0515339A (ja) * | 1991-07-10 | 1993-01-26 | Terumo Corp | タンパク質様組成物および高度侵襲用栄養剤ならびに肝疾患用栄養剤 |
US5405637A (en) * | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
US5714472A (en) * | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
JP3396090B2 (ja) * | 1994-08-18 | 2003-04-14 | 日東薬品工業株式会社 | 粉末栄養組成物 |
US5993221A (en) | 1997-05-01 | 1999-11-30 | Beth Israel Deaconess Medical Center, Inc. | Dietary formulation comprising arachidonic acid and methods of use |
MY129566A (en) * | 1999-01-19 | 2007-04-30 | Nestle Sa | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance |
EP1034704A1 (en) * | 1999-03-12 | 2000-09-13 | Societe Des Produits Nestle S.A. | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
US6998259B1 (en) * | 1999-05-20 | 2006-02-14 | Davisco Foods International | Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products |
JP2001233783A (ja) * | 2000-02-21 | 2001-08-28 | Terumo Corp | 術前栄養剤 |
JP2001247474A (ja) * | 2000-03-07 | 2001-09-11 | Snow Brand Milk Prod Co Ltd | 肝疾患予防及び/又は治療剤 |
NZ506866A (en) * | 2000-09-11 | 2003-05-30 | New Zealand Dairy Board | Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease |
JP2002226394A (ja) * | 2001-02-01 | 2002-08-14 | Meiji Milk Prod Co Ltd | 脂質代謝改善組成物 |
JP2002255824A (ja) * | 2001-02-27 | 2002-09-11 | Meiji Milk Prod Co Ltd | 免疫賦活組成物 |
MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
US6830766B2 (en) * | 2002-03-08 | 2004-12-14 | Mccabe David J. | High protein foodstuff |
JP4278028B2 (ja) * | 2002-12-18 | 2009-06-10 | 明治乳業株式会社 | 炎症性サイトカイン産生抑制活性を有するペプチド |
JP5015339B2 (ja) | 2011-06-02 | 2012-08-29 | 株式会社日本マイクロニクス | 液晶パネル点灯検査装置 |
-
2003
- 2003-11-12 TW TW092131634A patent/TWI317636B/zh not_active IP Right Cessation
- 2003-11-20 AR ARP030104300A patent/AR042107A1/es not_active Application Discontinuation
- 2003-11-20 MY MYPI20034459A patent/MY169519A/en unknown
- 2003-11-21 KR KR1020057009213A patent/KR101038354B1/ko active IP Right Grant
- 2003-11-21 US US10/535,585 patent/US7563458B2/en not_active Expired - Fee Related
- 2003-11-21 BR BR0316512-4A patent/BR0316512A/pt active Search and Examination
- 2003-11-21 EP EP03775857A patent/EP1575379B1/en not_active Expired - Lifetime
- 2003-11-21 CN CNB2003801091065A patent/CN100393243C/zh not_active Expired - Lifetime
- 2003-11-21 NZ NZ540775A patent/NZ540775A/en not_active IP Right Cessation
- 2003-11-21 CA CA2506603A patent/CA2506603C/en not_active Expired - Fee Related
- 2003-11-21 ES ES03775857T patent/ES2344640T3/es not_active Expired - Lifetime
- 2003-11-21 WO PCT/JP2003/014918 patent/WO2004047566A1/en active Application Filing
- 2003-11-21 JP JP2004555008A patent/JP2006515287A/ja not_active Withdrawn
- 2003-11-21 DK DK03775857.0T patent/DK1575379T3/da active
- 2003-11-21 DE DE60332760T patent/DE60332760D1/de not_active Expired - Lifetime
- 2003-11-21 AT AT03775857T patent/ATE468762T1/de not_active IP Right Cessation
-
2006
- 2006-02-20 HK HK06102231.9A patent/HK1083174A1/xx not_active IP Right Cessation
-
2009
- 2009-05-30 US US12/475,482 patent/US8778404B2/en not_active Expired - Fee Related
-
2010
- 2010-07-22 JP JP2010164805A patent/JP2011006425A/ja not_active Withdrawn
-
2013
- 2013-02-08 JP JP2013023027A patent/JP5688818B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
TW200412990A (en) | 2004-08-01 |
HK1083174A1 (en) | 2006-06-30 |
DE60332760D1 (de) | 2010-07-08 |
TWI317636B (en) | 2009-12-01 |
JP2006515287A (ja) | 2006-05-25 |
JP2013136602A (ja) | 2013-07-11 |
US20090233865A1 (en) | 2009-09-17 |
US7563458B2 (en) | 2009-07-21 |
WO2004047566A1 (en) | 2004-06-10 |
CN100393243C (zh) | 2008-06-11 |
JP2011006425A (ja) | 2011-01-13 |
CN1741749A (zh) | 2006-03-01 |
US8778404B2 (en) | 2014-07-15 |
ES2344640T3 (es) | 2010-09-02 |
ATE468762T1 (de) | 2010-06-15 |
NZ540775A (en) | 2007-08-31 |
BR0316512A (pt) | 2005-10-04 |
AU2003283831A1 (en) | 2004-06-18 |
MY169519A (en) | 2019-04-22 |
EP1575379A1 (en) | 2005-09-21 |
CA2506603C (en) | 2011-06-28 |
KR101038354B1 (ko) | 2011-06-01 |
CA2506603A1 (en) | 2004-06-10 |
DK1575379T3 (da) | 2010-09-13 |
EP1575379B1 (en) | 2010-05-26 |
KR20050083950A (ko) | 2005-08-26 |
JP5688818B2 (ja) | 2015-03-25 |
US20060073186A1 (en) | 2006-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR042107A1 (es) | Composiciones dieteticas | |
UY29195A1 (es) | Procesos para la preparacion de composiciones oleosas | |
MXPA03008823A (es) | Metodos, compuestos y composiciones para reducir la grasa corporal y modular el metabolismo de los acidos grasos. | |
CL2004001550A1 (es) | Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos. | |
DE60335708D1 (de) | E exprimieren | |
DK1911442T3 (da) | Præparat til forebyggelse og/eller behandling af vaskulære lidelser | |
EA201000400A1 (ru) | Твердые жировые композиции, содержащие полиненасыщенные жирные кислоты, и способы их получения и использования | |
NO20075009L (no) | Ernaeringstilsetning for HIV-pasienter | |
MX2010006199A (es) | Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina. | |
PE20151882A1 (es) | Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos | |
CO6160274A2 (es) | Enriquecimiento de productos nutricionales con extractos de oliva conteniendo hidroxitirosol y productos nutricionales enriquecidos con hidroxitirosol | |
CY1113437T1 (el) | Συνθεσεις με χαρακτηριστικα που προαγουν την υγεια και τη θρεψη, οι οποιες περιεχουν διεστεροποιημενα λιπιδια και εστερες φυτοστερολης και σχετικες μεθοδοι | |
MX338235B (es) | Microorganismos eucarioticos para producir lipidos y antioxidantes. | |
TR199700537A2 (xx) | Diyete uygun dengelenmi� s�t �r�n�. | |
ATE442050T1 (de) | Nahrungsergänzungsmittel oder functional food enthaltend íl-kombination | |
BRPI0408589A (pt) | suplementos dietéticos à base de fruta de açai e juçara | |
DK2021478T3 (da) | Delta-5-desaturase og anvendelse heraf i fremstillingen af flerumættede fedtsyrer | |
CL2011003077A1 (es) | Composición nutricional para mejorar el rendimiento cognitivo en un niño de 1 a 3 años, que comprende una o más fuentes de proteína, de carbohidratos disponibles, de lípidos, microorganismos probióticos, y prebióticos, en donde la una o más fuentes de lípidos comprende ácido docosahexaenoico (dha); métodos que comprenden dicha comp. | |
TW200515430A (en) | Base for electrical insulation oil | |
DK2018427T3 (da) | Delta-5-desaturase og anvendelse heraf i fremstillingen af flerumættede fedtsyrer | |
WO2005046580A3 (en) | Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism | |
CL2008003212A1 (es) | Grasa de leche de rumiante, para su aplicacion en alimentos, con un contenido de acidos grasos saturados menor a 50%, acidos grasos monoinsaturados superior al 47% y acidos grasos poliinsaturados superior a 5,5% sobre la base de acidos grasos totales; procedimiento de obtencion donde se somete a una o mas etapas de fraccionamiento por cristalizacion seguido por fraccionamiento por destilacion molecular. | |
MY143962A (en) | Oil or fat compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same | |
ATE443515T1 (de) | Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung | |
MXPA04001129A (es) | Mezclas de lipidos y productos de alimento que contienen acido graso oleico y acidos grasos omega-6, disenadas para incrementar el nivel intramiocelular de lipidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed, e.g., due to non-payment of fee |